Markers of Inflammation: Clinical Trials

5 trials for Markers of Inflammation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown, 1 completed, 1 not yet recruiting, 1 recruiting. 1 Early Phase 1, 1 Not applicable.

By phase and status

PhaseTrialsStatus
Early Phase 11Unknown 1
Not applicable1Unknown 1

Follow Markers of Inflammation: new trials by email Literature Review of Markers of Inflammation trials Research Report on Markers of Inflammation

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Health and Nutritional Outcomes Among Young Females and Children in Southwest Bangladesh
The follow-up aims to evaluate natural changes occurring from adolescence to young adulthood with respect to the study objectives due to lifestyle and environmental factors, without any intervention. - Nutritional Status, Micronutrient Status
Not yet recruitingUniversity of Copenhagen2402026-04-152026-05-06
Predictive Value of CRP, Albumin, CAR, and mGPS in Treatment Outcomes of DLBCL
Observational Assessment of Standard R-CHOP Treatment - DLBCL - Diffuse Large B Cell Lymphoma, Markers of Inflammation
RecruitingAin Shams University402025-05-052025-07-10
Effect of Hibiscus Sabdariffa Beverage
Effect of a Hibiscus sabdariffa beverage - Markers of Inflammation, Hyperglycemia, Postprandial
Not applicableUnknownInstituto Tecnológico y de Estudios Superiores de Occidente122021-06-122023-03-17
Pilot Study of the IL-1 Antagonist Anakinra for the Treatment of Endometriosis Related Symptoms
Anakinra 100Mg/0.67Ml Inj Syringe, Placebo - Endometriosis, Anakinra
Early Phase 1UnknownUniversity of California, San Diego202020-06-162021-05-28
Health Effects Following Use of Lead Free Ammunition Used With HK416
Lung Function Tests, Markers of Inflammation
CompletedOslo University Hospital552011-11-012013-10-16

Narrower conditions

Dendritic Cell Sarcoma, Interdigitating (1)  ·  Endometriosis (1)  ·  Hyperglycemia (1)  ·  Hyperinsulinism (1)  ·  Inflammation (1)

Broader conditions

Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Genital Diseases (1)  ·  Genital Diseases, Female (1)  ·  Glucose Metabolism Disorders (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Histiocytic Disorders, Malignant (1)  ·  Histiocytosis (1)  ·  Lymphatic Diseases (1)  ·  Metabolic Diseases (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Interleukin 1 Receptor Antagonist Protein (1)

Sponsors

Ain Shams University (1)  ·  Instituto Tecnológico y de Estudios Superiores de Occidente (1)  ·  Oslo University Hospital (1)  ·  University of California, San Diego (1)  ·  University of Copenhagen (1)

Countries

Bangladesh (1)  ·  Egypt (1)  ·  Mexico (1)  ·  Norway (1)  ·  United States (1)

Top investigators

Anne-Katrine Borander, MD (1)  ·  Doaa A Mohamed, MD (1)  ·  Johny S Kongerud, MD PhD (1)  ·  Kjetil Longva, PhD (1)  ·  Liv Ingunn Bjoner Sikkeland, PhD (1)  ·  Mahmoud M Ellithy, MD (1)  ·  Reham M Faheim, MD (1)  ·  Sanjay K Agarwal, MD (1)  ·  Shaimaa A Pessar, MD (1)

Results publications

PMID 28408655